Clínic-IDIBAPS optimizes its academic CAR-T therapy against multiple myeloma to address relapse
Researchers from Clínic-IDIBAPS, as part of the Clínic Barcelona Comprehensive Cancer Centre — a centre driven by Clínic, IDIBAPS and the Universit...
Unit News from Mieloma Múltiple y Amiloidosis
An experimental new CAR-T therapy shows high efficacy in multiple myeloma, even against treatment resistance
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
The Campus Clínic presents the Clínic Barcelona Comprehensive Cancer Center: a new model of international excellence in oncology
The creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translati...
Green light for ARI0002h CAR-T developed by Clínic-IDIBAPS for patients with multiple myeloma
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved AR...
Biomarkers of response to CAR T-cell therapy with ARI-0002h in refractory multiple myeloma are described
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy target...
Premiere of the documentary 'ARI, a story of love and life', about how the CAR-T became a reality at the Clínic
The Hospital Clínic Barcelona has presented the documentary ARI. "A story of love and lif", which tells the story of Ariana Benedé, Ari, and how a...
Presentation of the first model to predict response to CAR T-cell therapy in multiple myeloma
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this canc...
The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personal...
The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients...